Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light Cystoscopy
Press Release – Oslo, Norway, May 2, 2023: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that results from the Nordic Registry demonstrating benefits of Blue Light Cystoscopy (BLC[®]) were presented at the AUA 2023 Conference: the American Urological Association Annual Congress 2023 which was held April 28 – May 1, 2023 in Chicago, IL, USA. The study highlighted that BLC in surveillance of NMIBC* improves the detection of malignant lesions, enhances physicians’ confidence, and may reduce patients’ tumor burden through immediate fulguration. In addition, Photocure sponsored